article thumbnail

World Orphan Drug Congresses Europe vs. The US: Global Perspectives on Genetic Testing

Worldwide Clinical Trials

WODC Europe Key Discussion Points Ethics and Consent in Genetic Testing: Balancing Patient Privacy The conversation at WODC Europe centered heavily on ethical considerations around genomic and genetic data, particularly in obtaining patient consent for genetic testing. In-Vitro Diagnostic Regulation and The FDAs Final Rule The WODC U.S.

Genetics 130
article thumbnail

Centre for Genomic Regulation and Almirall join forces on skin cancer treatments

Pharma Times

The collaboration aims to develop novel preclinical models with a view to identifying new treatments

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The future of genomic medicine: can it fulfil its promises?

pharmaphorum

Here he gives us a deeper look at how genomic medicine is evolving and the barriers that are preventing it from reaching its full potential. I saw this, in particular, with the finishing of the human genome,” says Charlie. “At In reality, finishing the human genome was the first step of what is a long journey.”.

Genome 119
article thumbnail

New era of genomic medicine begins as UK approves Lilly’s Retsevmo

pharmaphorum

The UK regulator has authorised Eli Lilly’s targeted cancer drug Retsevmo for tumours with RET fusion positive lung cancers and thyroid cancers, which the company said could herald a new era of genomic medicine for the NHS. The post New era of genomic medicine begins as UK approves Lilly’s Retsevmo appeared first on.

Genome 111
article thumbnail

CDSCO declares sample of Bharat Biotech’s typhoid vaccine Typbar as NSQ

AuroBlog - Aurous Healthcare Clinical Trials blog

The drug regulator, in a drug alert issued, said that a batch of Typbar, manufactured by Bharat Biotech International Ltd in Genome Valley in Hyderabad, Telangana, failed […]

Vaccine 180
article thumbnail

Genome Edited Foods: Understanding the New FDA Guidance

XTalks

In a pivotal move for the food industry, the US Food and Drug Administration (FDA) has unveiled industry guidance for genome edited foods derived from plants. This landmark guidance aims to demystify the FDA’s risk-based approach towards both genome edited foods and all new plant varieties. What is Genome Editing?

Genome 86
article thumbnail

STAT+: At genome-editing summit, experts worry that rule changes on embryo research in China fall short

STAT News

That was the message Chinese scientists delivered Monday on the opening day of the Third International Summit on Human Genome Editing in London. Continue to STAT+ to read the full story…

Genome 98